טרידרם קרם
organon pharma israel ltd., israel - betamethasone as dipropionate; clotrimazole; gentamicin (as sulfate) - קרם - clotrimazole 10 mg/g; betamethasone as dipropionate 0.5 mg/g; gentamicin (as sulfate) 1 mg/g - corticosteroids, potent, other combinations - treatment of corticosteroid-responsive dermatoses when complicated by infections caused by bacteria (sensitive to gentamicin) and fungi (sensitive to clotrimazole) or when the possibility of such infections is suspected. the cream is suitable for the use of oozing eczema.
דיפרוג'נטה קרם
organon pharma israel ltd., israel - betamethasone as dipropionate; gentamicin (as sulfate) - קרם - gentamicin (as sulfate) 1 mg/g; betamethasone as dipropionate 0.5 mg/g - corticosteroids, potent, combinations with antibiotics - for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses when complicated by secondary infections caused by organisms susceptible to gentamycin.
דיפרוסאליק תרחיץ
organon pharma israel ltd., israel - betamethasone as dipropionate; salicylic acid - תרחיץ - salicylic acid 20 mg/g; betamethasone as dipropionate 0.5 mg/g - corticosteroids, potent, other combinations - provides anti-inflammatory, antipruritic, anti-allergic and keratinolytic activity in the topical management of subacute and chronic hyperkeratotic and dry dermatoses responsive to corticosteroid therapy
זולאייר 150 מג
novartis israel ltd - omalizumab - אבקה וממס להכנת תמיסה להזרקה - omalizumab 150 mg/dose - omalizumab - omalizumab - xolair is indicated for adults and adolescents (12 years of age and above) with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids. xolair has been shown to decrease the incidence of asthma exacerbations in these patients. safety and efficacy have not been established in other allergic conditions.
דיפרוספאן זריקה
organon pharma israel ltd., israel - betamethasone as dipropionate; betamethasone sodium phosphate - תרחיף להזרקה - betamethasone sodium phosphate 2 mg/ml; betamethasone as dipropionate 5 mg/ml - betamethasone - betamethasone - produces anti-inflammatory, anti rheumatic and anti-allergic action and is indicated for systemic and local therapy of acute and chronic corticosteroid-responsive disorders.
ציקלודרם c
trima israel pharmaceutical products maabarot ltd - ciclopirox olamine; clobetasone butyrate; gentamicin (as sulfate) - קרם - ciclopirox olamine 1 %; gentamicin (as sulfate) 0.1 %; clobetasone butyrate 0.05 % - combinations of corticosteroids - combinations of corticosteroids - for local treatment of skin inflammations accompanied by a mycotic and/or bacterial infection.
דואו סקביל
perrigo israel pharmaceuticals ltd - crotamiton; sulphur precipitated - קרם - crotamiton 10 %; sulphur precipitated 8 % - combinations of corticosteroids - combinations of corticosteroids - anti scabies treatment, symptomatic treatment of skin irritation.
סנדאימון ניאורל 50 מג כמוסות
novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.
סנדאימון ניאורל 100 מג כמוסות
novartis israel ltd - ciclosporin - קפסולות - ciclosporin 100 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.
סולו מדרול 40 מג
pfizer pfe pharmaceuticals israel ltd - methylprednisolone as sodium succinate - אבקה להמסה להזרקה\אינפוזיה - methylprednisolone as sodium succinate 40 mg/vial - methylprednisolone - methylprednisolone - glucocorticosteroid with anti-inflammatory and anti allergic effect.